Patients preferred Medtronic’s Brainsense adaptive DBS to traditional, continuous DBS in a trial, which found Brainsense safe and effective.| Parkinson's News Today
Parkinson's research and development moves far too slowly, says columnist Doc Irish, who argues for a more innovative and dynamic system.| Parkinson's News Today
The recipients of this year's grants include scientists and clinicians studying Parkinson’s biology, brain networks, and symptoms.| Parkinson's News Today
Expanding access to specialist healthcare for Parkinson's is increasingly urgent as the number of patients rise in the U.S., researchers say.| Parkinson's News Today
In the first of a four-part series on deep brain stimulation for Parkinson's, columnist Mollie Lombardi describes her initial DBS surgery.| Parkinson's News Today
Routine evaluations and adjustments provide columnist Mollie Lombardi the best results with her deep brain stimulator.| Parkinson's News Today
Michael S. Okun, MD, answers questions about deep brain stimulation for people with Parkinson's in our monthly "Expert Voices" series.| Parkinson's News Today
Insightec's Exablate Neuro device is approved by the FDA for use by some Parkinson's patients with moderate-to-severe motor complications.| Parkinson's News Today
A wide range of Parkinson's disease treatment options can help ease symptoms and make living with the disorder more manageable.| Parkinson's News Today
Columnist Christine Scheer compares her Parkinson's symptoms today with their severity before she had deep brain stimulation surgery.| Parkinson's News Today
The FDA approved a brain mapping tool that will enable doctors to more precisely use neuromodulation therapies like DBS.| Parkinson's News Today
The first patient has been dosed in a Phase 2a trial of Parkinson's therapy VTX3232, an oral medication designed to reduce inflammation.| Parkinson's News Today
Learn about Parkinson's disease, a condition that affects the brain, resulting in issues with movement, balance, and more.| Parkinson's News Today